about
Searching for a needle in a stack of needles: challenges in metaproteomics data analysis.glyXalign: high-throughput migration time alignment preprocessing of electrophoretic data retrieved via multiplexed capillary gel electrophoresis with laser-induced fluorescence detection-based glycoprofiling.Viewing the proteome: how to visualize proteomics data?The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation.Navigating through metaproteomics data: a logbook of database searching.Atmospheric pressure free liquid infrared MALDI mass spectrometry: toward a combined ESI/ MALDI-liquid chromatography interface.Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF.Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research.Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin.Impact of different influenza cultivation conditions on HA N-GlycosylationMALDI-TOF-MS analysis of sialylated glycans and glycopeptides using 4-chloro-α-cyanocinnamic acid matrix.MIRAGE: the minimum information required for a glycomics experimentImpact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets.The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic dataCapillary electrophoresis/mass spectrometry of APTS-labeled glycans for the identification of unknown glycan species in capillary electrophoresis/laser-induced fluorescence systems.Sample prefractionation with liquid isoelectric focusing enables in depth microbial metaproteome analysis of mesophilic and thermophilic biogas plants.Purification and characterization of hydroquinone dioxygenase from Sphingomonas sp. strain TTNP3Community shifts in a well-operating agricultural biogas plant: how process variations are handled by the microbiome.N-Glycosylation Fingerprinting of Viral Glycoproteins by xCGE-LIF.Metaproteomics of activated sludge from a wastewater treatment plant - a pilot study.Colonic metaproteomic signatures of active bacteria and the host in obesity.Sialic acid-specific affinity chromatography for the separation of erythropoietin glycoforms using serotonin as a ligand.Site-specific O-Glycosylation Analysis of Human Blood Plasma ProteinsProteotyping of biogas plant microbiomes separates biogas plants according to process temperature and reactor type.Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation.Fractionation of biogas plant sludge material improves metaproteomic characterization to investigate metabolic activity of microbial communities.Quantitative Assessment of Sialo-Glycoproteins and N-Glycans during Cardiomyogenic Differentiation of Human Induced Pluripotent Stem Cells.Sialylation Is Dispensable for Early Murine Embryonic Development in Vitro.Ezrin and HNRNP expression correlate with increased virus release rate and early onset of virus-induced apoptosis of MDCK suspension cells.Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus MacaquesMonitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension.Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.Vaccine production: upstream processing with adherent or suspension cell lines.Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity.CAP, a new human suspension cell line for influenza virus production.The impact of sequence database choice on metaproteomic results in gut microbiota studies.High-density microcarrier cell cultures for influenza virus production.MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach.
P50
Q30581490-849C0CBD-887C-4472-A5AD-7F46A144576DQ30620808-83C55674-9C0D-4D7F-A524-BF334B5DB27FQ30878062-4F2129BE-7206-49B8-912D-B536A675E485Q30889304-46846842-985C-4691-9D01-6F8AC316DC73Q30911195-0CC66659-E189-4C0D-A7DB-AF3F10182AC1Q33441734-C8737F29-0958-4448-A90D-9D85199D4068Q33708031-52AEE272-9C8D-4C12-8130-B0B311DB63EFQ33718742-7F7A9898-329F-42C8-AFC6-282FFF0BE506Q34098121-03078007-BDB7-44F7-9F6F-B18E834BB7E4Q34176750-9AEAACEE-7954-4BAF-A5AF-4DB2E5F6526BQ34270136-B407AB69-4544-4864-B12A-70BCC4CC1BB0Q34411320-FA3ECD20-03E4-4F5D-BBDB-944300D8962AQ34538848-E33DFC27-C253-4B2E-9B52-8A168FBE73D3Q34540880-A16F0B7C-3099-46E2-A471-A987A6AC2153Q34573489-3ADFC18B-7549-4F39-97A4-022EEDE85F3FQ34984920-EF792EE6-E88A-4FDC-8574-9F1B9D53B39AQ35059722-D6F031E7-E954-47DC-A617-8B6E1455E4D9Q35568051-FDC1D227-45F9-4229-A0BF-125C8EB22FC3Q35638769-D6329964-CDBD-4B21-BCD0-0FD555AD5B1AQ35690036-660AA0B4-6E59-46DA-93C2-95555A722BB0Q35706463-DCF97FFE-E25C-43D0-919D-9E7B314E5FEEQ35740755-960AAC5B-047D-4AC7-88F2-CE79202B2BA3Q35916470-94413F75-4EA6-42A4-B90C-C2FE5E0F3E72Q36539502-EFC1040D-1233-44E8-95A7-38A88935480AQ37125959-F4FE11C4-A2C7-4692-8D39-33D7D4807145Q38320923-C8F70486-30DB-45E0-953B-BF3A2C95B6B2Q38408476-010B7E59-5875-480D-97CA-1ABE2D6C2BC1Q38683295-78E57828-CD8D-4F08-8700-66D69286EACFQ38709012-339C02C0-118C-4803-A137-C44B4B5C250FQ38748783-AE1308FA-9C96-4A1A-B203-0E5CF447C4F8Q38836455-D246E6EB-76B1-445E-8276-EE00EB455F33Q38884937-9B2ED9C6-A070-4DF4-98A0-1F9A88B13468Q38886845-BD99EB0E-0499-4A31-A528-39B84080DB0AQ39050924-3A125B5A-7878-46D7-BC59-D7297FFD7A3EQ39229311-646351A2-CCA2-4B3D-B07F-AD078C87A0D8Q39310257-15412EB0-03A5-4B22-9537-05EF43D1DD7EQ39348860-91E60602-B8F7-4808-AD7D-C4BD3522A0C6Q39594075-A51FBA96-328F-4628-B356-D0BED855F735Q39682441-33C663D6-C714-4A1C-9B09-F8C170612F13Q39708483-875FA99B-5B5F-404B-803D-1216DE989F7D
P50
description
German biotechnologist
@en
biotechnoloog
@nl
deutscher Biotechnologe
@de
name
Erdmann Rapp
@ast
Erdmann Rapp
@de
Erdmann Rapp
@en
Erdmann Rapp
@es
Erdmann Rapp
@fr
Erdmann Rapp
@nl
Erdmann Rapp
@sl
type
label
Erdmann Rapp
@ast
Erdmann Rapp
@de
Erdmann Rapp
@en
Erdmann Rapp
@es
Erdmann Rapp
@fr
Erdmann Rapp
@nl
Erdmann Rapp
@sl
prefLabel
Erdmann Rapp
@ast
Erdmann Rapp
@de
Erdmann Rapp
@en
Erdmann Rapp
@es
Erdmann Rapp
@fr
Erdmann Rapp
@nl
Erdmann Rapp
@sl
P214
P227
P106
P1153
7004142540
P21
P214
P227
P2798
P31
P496
0000-0001-6618-2626
P569
1968-01-01T00:00:00Z
P734
P735
P7859
viaf-1095004